The usefulness of liver stiffness measurement using FibroScan in chronic hepatitis C in South Korea: A multicenter, prospective study

Journal of Gastroenterology and Hepatology (Australia)

Volumn 26, Issue 1, 2011, Pages 171-178

  Kim, Seung Up ^a   Jang, Hui Won ^a   Cheong, Jae Youn ^b,d   Kim, Ja Kyung ^a,b   Lee, Myung Hee ^b,d   Kim, Dong Joon ^c   Yang, Jin Mo ^e   Cho, Sung Won ^b,d   Lee, Kwan Sik ^a,b   Choi, Eun Hee ^a   Park, Young Nyun ^a   Han, Kwang Hyub ^a,b  

^a Yonsei University College of Medicine   (South Korea)

^b Liver Cirrhosis Clinical Research Centre   (South Korea)

^c Hallym University College of Medicine   (South Korea)

^d Ajou University School of Medicine   (South Korea)

^e The Catholic University of Korea College of Medicine   (South Korea)

Author keywords

Chronic hepatitis C; Fibroscan; Fibrosis; Liver stiffness measurement; Transient elastography

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN;

ADULT; AGE PLATELET INDEX; AGE SPLEEN PLATELET RATIO INDEX; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; ASPARTATE AMINOTRANSFERASE TO PLATELET RATIO INDEX; BILIRUBIN BLOOD LEVEL; CLINICAL EVALUATION; CLINICAL TRIAL; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; FATTY LIVER; FEMALE; HEPATITIS C; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INTERNATIONAL NORMALIZED RATIO; LIVER BIOPSY; LIVER FIBROSIS; LIVER FUNCTION TEST; LIVER STIFFNESS MEASUREMENT; MAJOR CLINICAL STUDY; MALE; MEASUREMENT; MEDICAL HISTORY; MULTICENTER STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTHROMBIN TIME; RECEIVER OPERATING CHARACTERISTIC; SCORING SYSTEM; SOUTH KOREA; THROMBOCYTE;

EID: 78650355672     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/j.1440-1746.2010.06385.x     Document Type: Article

References (42)

1. Ryder SD, Irving WL, Jones DA, Neal KR, Underwood JC. Progression of hepatic fibrosis in patients with hepatitis C: a prospective repeat liver biopsy study. Gut 2004; 53: 451-5.
2. Bravo AA, Sheth SG, Chopra S. Liver biopsy. N. Engl. J. Med. 2001; 344: 495-500.
3. Castera L, Vergniol J, Foucher J et al. Prospective comparison of transient elastography, Fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C. Gastroenterology 2005; 128: 343-50.
4. Ziol M, Handra-Luca A, Kettaneh A et al. Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with chronic hepatitis C. Hepatology 2005; 41: 48-54.
5. Marcellin P, Ziol M, Bedossa P et al. Non-invasive assessment of liver fibrosis by stiffness measurement in patients with chronic hepatitis B. Liver Int. 2009; 29: 242-7.
6. Sandrin L, Fourquet B, Hasquenoph JM et al. Transient elastography: a new noninvasive method for assessment of hepatic fibrosis. Ultrasound Med. Biol. 2003; 29: 1705-13.
7. Chan HL, Wong GL, Choi PC et al. Alanine aminotransferase-based algorithms of liver stiffness measurement by transient elastography (Fibroscan) for liver fibrosis in chronic hepatitis B. J. Viral Hepat. 2009; 16: 36-44.
8. Kim DY, Kim SU, Ahn SH et al. Usefulness of FibroScan for detection of early compensated liver cirrhosis in chronic hepatitis B. Dig. Dis. Sci. 2009; 54: 1758-63.
9. Nitta Y, Kawabe N, Hashimoto S et al. Liver stiffness measured by transient elastography correlates with fibrosis area in liver biopsy in patients with chronic hepatitis C. Hepatol. Res. 2009; 39: 675-84.
10. Takeda T, Yasuda T, Nakayama Y et al. Usefulness of noninvasive transient elastography for assessment of liver fibrosis stage in chronic hepatitis C. World J. Gastroenterol. 2006; 12: 7768-73.
11. Roulot D, Czernichow S, Le Clesiau H, Costes JL, Vergnaud AC, Beaugrand M. Liver stiffness values in apparently healthy subjects: influence of gender and metabolic syndrome. J. Hepatol. 2008; 48: 606-13.
12. Kim SU, Kim DY, Lee CK et al. Ascitic fluid infection in patients with hepatitis B virus-related liver cirrhosis: culture-negative neutrocytic ascites versus spontaneous bacterial peritonitis. J. Gastroenterol. Hepatol. 2010; 25: 122-8.
13. Coco B, Oliveri F, Maina AM et al. Transient elastography: a new surrogate marker of liver fibrosis influenced by major changes of transaminases. J. Viral Hepat. 2007; 14: 360-9.
14. Arena U, Vizzutti F, Corti G et al. Acute viral hepatitis increases liver stiffness values measured by transient elastography. Hepatology 2008; 47: 380-4.
15. Sagir A, Erhardt A, Schmitt M, Haussinger D. Transient elastography is unreliable for detection of cirrhosis in patients with acute liver damage. Hepatology 2008; 47: 592-5.
16. Kim SU, Han KH, Park JY et al. Liver stiffness measurement using FibroScan is influenced by serum total bilirubin in acute hepatitis. Liver Int. 2009; 29: 810-15.
17. Millonig G, Reimann FM, Friedrich S et al. Extrahepatic cholestasis increases liver stiffness (FibroScan) irrespective of fibrosis. Hepatology 2008; 48: 1718-23.
18. Bedossa P, Dargere D, Paradis V. Sampling variability of liver fibrosis in chronic hepatitis C. Hepatology 2003; 38: 1449-57.
19. Lucidarme D, Foucher J, Le Bail B et al. Factors of accuracy of transient elastography (fibroscan) for the diagnosis of liver fibrosis in chronic hepatitis C. Hepatology 2009; 49: 1083-9.
20. Lebray P, Varnous S, Charlotte F, Varaut A, Poynard T, Ratziu V. Liver stiffness is an unreliable marker of liver fibrosis in patients with cardiac insufficiency. Hepatology 2008; 48: 2089.
21. Brunt EM, Janney CG, Di Bisceglie AM, Neuschwander-Tetri BA, Bacon BR. Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions. Am. J. Gastroenterol. 1999; 94: 2467-74.
22. Kleiner DE, Brunt EM, Van Natta M et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 2005; 41: 1313-21.
23. Kim SU, Ahn SH, Park JY et al. Liver stiffness measurement in combination with noninvasive markers for the improved diagnosis of B-viral liver cirrhosis. J. Clin. Gastroenterol. 2009; 43: 267-71.
24. Kim SU, Ahn SH, Park JY et al. Prediction of postoperative hepatic insufficiency by liver stiffness measurement (FibroScan) before curative resection of hepatocellular carcinoma: a pilot study. Hepatol. Int. 2008; 2: 471-7.
25. Poynard T, Bedossa P. Age and platelet count: a simple index for predicting the presence of histological lesions in patients with antibodies to hepatitis C virus. METAVIR and CLINIVIR Cooperative Study Groups. J. Viral Hepat. 1997; 4: 199-208.
26. Wai CT, Greenson JK, Fontana RJ et al. A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C. Hepatology 2003; 38: 518-26.
27. Kim BK, Kim SA, Park YN et al. Noninvasive models to predict liver cirrhosis in patients with chronic hepatitis B. Liver Int. 2007; 27: 969-76.
28. Castera L, Negre I, Samii K, Buffet C. Pain experienced during percutaneous liver biopsy. Hepatology 1999; 30: 1529-30.
29. Rousselet MC, Michalak S, Dupre F et al. Sources of variability in histological scoring of chronic viral hepatitis. Hepatology 2005; 41: 257-64.
30. Castera L, Forns X, Alberti A. Non-invasive evaluation of liver fibrosis using transient elastography. J. Hepatol. 2008; 48: 835-47.
31. Kim SU, Kim DY, Park JY et al. How can we enhance the performance of liver stiffness measurement using FibroScan in diagnosing liver cirrhosis in patients with chronic hepatitis B? J. Clin. Gastroenterol. 2010; 44: 66-71.
32. Wong GL, Wong VW, Choi PC et al. Clinical factors associated with liver stiffness in hepatitis B e antigen-positive chronic hepatitis B patients. Clin. Gastroenterol. Hepatol. 2009; 7: 227-33.
33. Fung J, Lai CL, Fong DY, Yuen JC, Wong DK, Yuen MF. Correlation of liver biochemistry with liver stiffness in chronic hepatitis B and development of a predictive model for liver fibrosis. Liver Int. 2008; 28: 1408-16.
34. Foucher J, Castéra L, Bernard PH et al. Prevalence and factors associated with failure of liver stiffness measurement using FibroScan in a prospective study of 2114 examinations. Eur. J. Gastroenterol. Hepatol. 2006; 18: 411-12.
35. Colombo S, Belloli L, Buonocore M et al. Liver Stiffness values in the normal population: a studying voluntary blood donors. Hepatology 2008; 48 (Suppl.): A995.
36. Colombo S, Belloli L, Buonocore M, Jamoletti C, Zaccanelli E, Del Poggio P. True normal liver stiffness measurement (LSM) and its determinants. Hepatology 2009; 50 (Suppl.): 741A.
37. Arena U, Vizzutti F, Abraldes JG et al. Reliability of transient elastography for the diagnosis of advanced fibrosis in chronic hepatitis C. Gut 2008; 57: 1288-93.
38. Lupsor M, Stefanescu H, Sparchez Z et al. The influence of fatty load on liver stiffness in chronic hepatitis C patients. J. Hepatol. 2008; 48 (Suppl. 2): S278.
39. Gaia S, Carenzi S, Brunello F et al. Is liver stiffness measurement different in patients with NASH or with viral hepatitis? Dig. Liver Dis. 2008; 40: A128.
40. Kim SU, Kim DY, Park JY, Ahn SH, Paik YH, Choi EH. The impact of steatosis on liver stiffness measurement using fibroscan in patients with hepatitis B virus related chronic liver disease in Korea. Hepatology 2008; 48 (Suppl. 4): A994.
41. Regev A, Berho M, Jeffers LJ et al. Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection. Am. J. Gastroenterol. 2002; 97: 2614-18.
42. Asian Pacific Association for the Study of the Liver (APASL) Hepatitis C Working Party et al. Asian Pacific Association for the Study of the Liver consensus statements on the diagnosis, management and treatment of hepatitis C virus infection. J. Gastroenterol. Hepatol. 2007; 22: 615-33.